Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic

References

• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27:992–1000.e3
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200604-covid-19-sitrep-136.pdf?sfvrsn=fd36550b_2
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Lin L, Lu L, Cao W, et al. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727–732.
   PubMed Web of Science ®Google Scholar
• Toniati P, Piva S, Cattalini M, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020;19(7):102568.
   PubMed Web of Science ®Google Scholar
• Mehta PM, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034.
   PubMed Web of Science ®Google Scholar
• Abrishami A, Samavat S, Behnam B, et al. Clinical course, imaging features, and outcomes of COVID-19 in kidney transplant recipients. Eur Urol. 2020. DOI:10.1016/j.eururo.2020.04.064
   PubMed Web of Science ®Google Scholar
• Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382(25):2475–2477.
   PubMedGoogle Scholar
• Alberici F, Delbarba E, Manenti C, et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. 2020;97:1083–1088.
   PubMed Web of Science ®Google Scholar
• Banerjee D, Popoola J, Shah S, et al. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020; 97:1076–1082.
   PubMed Web of Science ®Google Scholar
• Fernández-Ruiz M, Andrés A, Loinaz C, et al. COVID-19 in solid organ transplant recipients: a single-center case series from Spain. Am J Transplant. 2020;20(7):1849–1858.
   PubMed Web of Science ®Google Scholar
• Columbia University Kidney Transplant Program. Early description of coronavirus 2019 disease in kidney transplant recipients in New York. J Am Soc Nephrol. 2020;31:1150–1156.
   PubMed Web of Science ®Google Scholar
• Husain SA, Dube G, Morris H, et al. Early outcomes of outpatient management of kidney transplant recipients with coronavirus disease 2019. Clin J Am Soc Nephrol. 2020. DOI:10.2215/CJN.05170420
   Web of Science ®Google Scholar
• Montagud-Marrahi E, Cofan F, Torregrosa JV, et al. Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients. Am J Transplant. 2020. DOI:10.1111/ajt.15970
   PubMedGoogle Scholar
• Nair V, Jandovitz N, Hirsch JS, et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020;20(7):1819–1825.
   PubMed Web of Science ®Google Scholar
• Trujillo H, Caravaca-Fontán F, Sevillano Á, et al. SARS-CoV-2 infection in hospitalized patients with kidney disease. Kidney Int Rep. 2020;5:905–909.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen Y, Yuan Q, et al. Identification of kidney transplant recipients with coronavirus disease 2019. Eur Urol. 2020;77:742–747.
   PubMed Web of Science ®Google Scholar
• Zhu L, Gong N, Liu B, et al. Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China. Eur Urol. 2020;77:748–754.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):e206775.
   Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239.
   PubMed Web of Science ®Google Scholar
• Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 2020;20(7):1800–1808.
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
   PubMed Web of Science ®Google Scholar
• Hou W, Zhang W, Jin R, et al. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infect Dis (Lond). 2020;52(7):498–505.
   PubMed Web of Science ®Google Scholar
• Oltean S, Ţǎţulescu D, Bondor C, et al. Charlson’s weighted index of comorbidities is useful in assessing the risk of death in septic patients. J Crit Care. 2012;27(4):370–375.
   PubMed Web of Science ®Google Scholar
• Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-guidelines of the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13512.
   PubMed Web of Science ®Google Scholar
• Effect of dexamethasone in hospitalized patients with COVID-19—preliminary report. 22 Jun 2020. Available from: https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1.full.pdf
   Google Scholar
• Gleeson SE, Formica RN, Marin EP. Outpatient management of the kidney transplant recipient during the SARS-CoV-2 virus pandemic. Clin J Am Soc Nephrol. 2020;15:892–895.
   PubMed Web of Science ®Google Scholar
• Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218.
   PubMed Web of Science ®Google Scholar
• Batlle D, Soler MJ, Sparks MA, et al. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020;31(7):1380–1383.
   PubMed Web of Science ®Google Scholar
• Chowdhury MS, Rathod J, Gernsheimer J. A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19. Acad Emerg Med. 2020;27(6):493–504.
   PubMed Web of Science ®Google Scholar
• Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020;369:m1849.
   PubMed Web of Science ®Google Scholar
• Meyerowitz EA, Vannier AGL, Friesen MGN, et al. Rethinking the role of hydroxychloroquine in the treatment of COVID-19. FASEB J. 2020;34(5):6027–6037.
   PubMed Web of Science ®Google Scholar
• Hoek RAS, Manintveld OC, Betjes MGH, et al. Covid-19 in solid organ transplant recipients: a single center experience. Transpl Int. 2020. DOI:10.1111/tri.13662
   Google Scholar
• World Health Organization. Targeted update: safety and efficacy of hydroxychloroquine or chloroquine for treatment of COVID-19. Available from: https://www.who.int/publications/m/item/targeted-update-safety-and-efficacy-of-hydroxychloroquine-or-chloroquine-for-treatment-of-covid-19
   Google Scholar